Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics

Nakano, Masataka; Otsuka, Fumiyuki; Yahagi, Kazuyuki; Sakakura, Kenichi; Kutys, Robert; Ladich, Elena R.; Finn, Aloke V.; Kolodgie, Frank D.; Virmani, Renu
November 2013
European Heart Journal;Nov2013, Vol. 34 Issue 42, p3304
Academic Journal
No abstract available.


Related Articles

  • Natural history of low-intensity neointimal tissue after an everolimus-eluting stent implantation: a serial observation with optical coherence tomography. Shibuya, Masahiko; Fujii, Kenichi; Fukunaga, Masashi; Imanaka, Takahiro; Miki, Kojiro; Tamaru, Hiroto; Ohyanagi, Mitsumasa; Masuyama, Tohru // Heart & Vessels;Jan2015, Vol. 30 Issue 1, p136 

    Although previous optical coherence tomography (OCT) studies reported that restenosis tissue after implantation of a drug-eluting stent (DES) was composed of a variety of cells, the clinical significance of morphologic characteristics for in-stent neointimal tissue as assessed by OCT has not...

  • Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation. Ishii, Hideshi; Kataoka, Toru; Kobayashi, Yoshiki; Tsumori, Takara; Takeshita, Hiroaki; Matsumoto, Ryo; Shirai, Nobuyuki; Nishioka, Hiroki; Hasegawa, Takao; Nakata, Shinji; Shimada, Yoshihisa; Ehara, Shoichi; Muro, Takashi; Yoshiyama, Minoru // Heart & Vessels;Nov2011, Vol. 26 Issue 6, p572 

    Drug-eluting stents reduce restenosis due to neointimal growth suppression. Considering long-term outcomes, it is both difficult and important to predict drug-eluting stent restenosis. Thus, this study was designed to examine the utility of myocardial fractional flow reserve (FFR) as a predictor...

  • Dual antiplatelet therapy and drug eluting stents: a marriage of convenience. Benezet-Mazuecos, Juan; Ibanez, Borja; Badimon, Juan J. // Thrombosis Journal;2007, Vol. 5, p15 

    The article discusses the benefits of dual antiplatelet therapy and drug eluting stents (DES) as a way to address restenosis and thrombosis. According to the author, the introduction of dual antiplatelet therapy has decreased the rate of stent thrombosis. Also in one study, the authors used...

  • Current Status of Intravascular Stents as Delivery Devices to Prevent Restenosis. Pearce, Benjamin J.; McKinsey, James F. // Vascular & Endovascular Surgery;Jul/Aug2003, Vol. 37 Issue 4, p231 

    The acute technical success of percutaneous transluminal angioplasty (PTA) has been improved with the use of intravascular stents. However, stent placement has led to the development of an increased myointimal hyperplastic response leading to late reduction in vessel lumen. Restenosis (= 50%...

  • Biodegradable stent. Doo Yeon Kwon; Jae Il Kim; Da Yeon Kim; Hwi Ju Kang; Bong Lee; Kang Woo Lee; Moon Suk Kim // Journal of Biomedical Science & Engineering;Apr2012, Vol. 5 Issue 4, p208 

    The bare metal stent (BMS) used in the blood vessel caused the restenosis after the operation due to formation and proliferation of neointimal. Recently, as a method to overcome the problems of BMS, drug eluting stent (DES) is developed and being applied to human body which has drug reducing...

  • Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation. Komatsu, Takaaki; Yaguchi, Isao; Komatsu, Sachiko; Nakahara, Shiro; Kobayashi, Sayuki; Sakai, Yoshihiko; Taguchi, Isao // Texas Heart Institute Journal;Aug2015, Vol. 42 Issue 4, p327 

    Percutaneous coronary intervention is established as an effective treatment for patients with ischemic heart disease; in particular, drug-eluting stent implantation is known to suppress in-stent restenosis. Diabetes mellitus is an independent risk factor for restenosis, so reducing insulin...

  • Acute stress-induced late drug-eluting stent thrombosis leading to hyperacute myocardial infarction. Özeke, Özcan; Ömürlü, Kenan; İlkay, Erdoğan // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Feb2010, Vol. 10 Issue 1, p94 

    The article presents a study the examines the efficacy of drug-eluting stents (DES) in reducing restenosis and reintervention compared with bare-metal stents (BMS).

  • Death rates higher with drug-eluting than bare metal stents.  // Reactions Weekly;4/4/2009, Issue 1246, p4 

    The article discusses a study which examined death rates associated with drug eluting and bare metal stents. Autopsy cases from the CVPath registry of coronary arteries were reviewed in the study. Findings showed that stent-related death was higher with use of drug-eluting stents. Thrombosis and...

  • OCT demonstrating neoatherosclerosis as part of the continuous process of coronary artery disease. Zhang, B.-C.; Karanasos, A.; Regar, E. // Herz;Sep2015, Vol. 40 Issue 6, p845 

    Although the advent of drug-eluting stents has reduced the rates of target vessel revascularization, there are observations of ongoing stent failure occurring very late after stent implantation and presenting as very late restenosis or as very late stent thrombosis. The de novo development of...

  • Oral Mycophenolate Mofetil Prevents In-Stent Intimal Hyperplasia Without Edge Effect. Ilkay, Erdogan; Tirikli, Latif; Ozercan, Ibrahim; Yavuzkir, Mustafa; Karaca, Ilgin; Rahman, Ali; Arslan, Nadi // Angiology;Oct/Nov2006, Vol. 57 Issue 5, p577 

    Neointimal hyperplasia is in the forefront in in-stent restenosis. Prevention of in-stent restenosis is possible by reducing and inhibiting the hyperplasia of smooth muscle cells. The authors planned this study to test the hypothesis that when administered orally, mycophenolate mofetil (MMF)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics